These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37892833)
1. Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year Survival. Tiosano S; Banai A; Mulla W; Goldenberg I; Bayshtok G; Amit U; Shlomo N; Nof E; Rosso R; Glikson M; Guetta V; Barbash I; Beinart R J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892833 [TBL] [Abstract][Full Text] [Related]
2. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies. Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study. Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932 [TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867 [TBL] [Abstract][Full Text] [Related]
5. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update. Chen S; Chun KRJ; Ling Z; Liu S; Zhu L; Wang J; Schratter A; Acou WJ; Kiuchi MG; Yin Y; Schmidt B J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34208117 [TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial. Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184 [TBL] [Abstract][Full Text] [Related]
9. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727 [TBL] [Abstract][Full Text] [Related]
10. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918 [TBL] [Abstract][Full Text] [Related]
11. Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation. Maarse M; Seiffge DJ; Werring DJ; Boersma LVA; ; ; Aarnink EW; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zielinski K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; de Prado AP; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Alvarez XM; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Bergmann MW; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; van Dijk VF; Rensing BJWM; Zietz A; Paciaroni M; Caso V; Koga M; Toyoda K; Kallmünzer B; Cappellari M; Wilson D; Engelter S; Swaans MJ; JAMA Neurol; 2024 Sep; 81(11):1150-8. PubMed ID: 39374446 [TBL] [Abstract][Full Text] [Related]
12. Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Acute and long-term outcome of occluder implantation in the LAARGE Registry. Brachmann J; Lewalter T; Akin I; Sievert H; Geist V; Zeymer U; Erkapic D; Mudra H; Pleger S; Hochadel M; Senges J J Interv Card Electrophysiol; 2020 Sep; 58(3):273-280. PubMed ID: 31707534 [TBL] [Abstract][Full Text] [Related]
13. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794 [TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex. Zeitler EP; Kearing S; Coylewright M; Nair D; Hsu JC; Darden D; O'Malley AJ; Russo AM; Al-Khatib SM Circulation; 2023 Feb; 147(7):586-596. PubMed ID: 36780379 [TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
16. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation. Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705 [TBL] [Abstract][Full Text] [Related]
17. Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation. Maille B; Defaye P; Bentounes SA; Herbert J; Clerc JM; Pierre B; Torras O; Deharo JC; Fauchier L Mayo Clin Proc; 2024 May; 99(5):754-765. PubMed ID: 38180394 [TBL] [Abstract][Full Text] [Related]
18. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk. Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892 [TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study. Waranugraha Y; Lin LY; Tsai CT Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]